Trademarkia Logo

Canada

C$
Trademark Search in Canada
IMC

View On IC.GC.CA

IMC
REGISTERED

on 26 Sept 2022

Last Applicant/ Owned by

I.M.C. HOLDINGS LTD.

Arches House4690500 Kibbutz Glil-Yam,

IL

Serial Number

1869895 filed on 27th Nov 2017

Registration Number

TMA1143217 registered on 26th Sept 2022

Registration expiry Date

26th Sept 2032

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

IMC

Trademark usage description

cannabis extracts, namely oils and resins for cosmetic purposes. medical cannabis and dried cannabis flowers for the treatment of: acute and chronic Read More

Classification Information

Class [003]
Cannabis extracts, namely oils and resins for cosmetic purposes.

Classification kind code

11

Class [005]
Medical cannabis and dried cannabis flowers for the treatment of: acute and chronic pain, muscle tension, muscle spasms, multiple sclerosis, epilepsy, nausea, vomiting, wasting syndrome, loss of appetite, HIV, AIDS, cancer, arthritis and musculoskeletal conditions, namely osteoarthritis, rheumatoid arthritis and fibromyalgia, movement disorders, namely Huntington's disease and Parkinson's disease, glaucoma, Tourette's syndrome, psychiatric disorders, namely bi-polar disorder, anxiety and depression, sleep disorders, namely insomnia and post-traumatic stress disorder, gastrointestinal disorders, namely irritable bowel disease, inflammatory bowel disease, Crohn's disease and colitis, spinal cord injury, inflammation; medical marijuana for the treatment of: acute and chronic pain, muscle tension, muscle spasms, multiple sclerosis, epilepsy, nausea, vomiting, wasting syndrome, loss of appetite, HIV, AIDS, cancer, arthritis and musculoskeletal conditions, namely osteoarthritis, rheumatoid arthritis and fibromyalgia, movement disorders, namely Huntington's disease and Parkinson's disease, glaucoma, Tourette's syndrome, psychiatric disorders, namely bi-polar disorder, anxiety and depression, sleep disorders, namely insomnia and post-traumatic stress disorder, gastrointestinal disorders, namely irritable bowel disease, inflammatory bowel disease, Crohn's disease and colitis, spinal cord injury, inflammation; cannabis extracts, namely oils and resins for the treatment of: acute and chronic pain, muscle tension, muscle spasms, multiple sclerosis, epilepsy, nausea, vomiting, wasting syndrome, loss of appetite, HIV, AIDS, cancer, arthritis and musculoskeletal conditions, namely osteoarthritis, rheumatoid arthritis and fibromyalgia, movement disorders, namely Huntington's disease and Parkinson's disease, glaucoma, Tourette's syndrome, psychiatric disorders, namely bi-polar disorder, anxiety and depression, sleep disorders, namely insomnia and post-traumatic stress disorder, gastrointestinal disorders, namely irritable bowel disease, inflammatory bowel disease, Crohn's disease and colitis, spinal cord injury, inflammation.

Classification kind code

11

Class [029]
Cannabis extracts, namely oils and resins for food.

Classification kind code

11

Class [032]
Cannabis extracts, namely oils and resins for beverages.

Classification kind code

11

Class [034]
Dried cannabis flowers for smoking purposes; cannabis extracts, namely oils and resins for electronic cigarettes, vaporizing and recreational uses.

Classification kind code

11

Mark Details

Serial Number

1869895

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 27
on 27th Dec 2021		Approval Notice Sent
Submitted for opposition 12
on 11th Aug 2021		Extension of Time
Submitted for opposition 12
on 26th Nov 2020		Extension of Time
Submitted for opposition 15
on 14th Apr 2020		Correspondence Created
Submitted for opposition 12
on 29th Jul 2019		Extension of Time
Submitted for opposition 22
on 21st Jan 2019		Search Recorded
Submitted for opposition 20
on 21st Jan 2019		Examiner's First Report
Submitted for opposition 31
on 29th Nov 2017		Formalized
Submitted for opposition 1
on 28th Nov 2017		Created
Submitted for opposition 30
on 27th Nov 2017		Filed